| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.1M | +73.4% |
| R&D Expense | $94.3M | -20.1% |
| SG&A Expense | $22.4M | -22.0% |
| Operating Income | -$104.6M | +25.2% |
| Income Tax | $0 | — |
| Net Income | -$99.5M | +21.8% |
| EPS (Basic) | -$1.29 | +23.2% |
| EPS (Diluted) | -$1.29 | +23.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.3M | +182.6% |
| Short-term Investments | $68.0M | -43.9% |
| Current Assets | $105.7M | -22.2% |
| Total Assets | $141.3M | -19.5% |
| Current Liabilities | $53.0M | +106.7% |
| Total Liabilities | $72.7M | +65.0% |
| Stockholders' Equity | $68.6M | -47.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.3M | +45.3% |
| Capital Expenditures | $67K | -91.2% |
| Investing Cash Flow | $53.5M | -40.7% |
| Financing Cash Flow | $24.8M | — |
| Free Cash Flow | -$56.4M | +45.6% |